Pricing
  1. JP-listed companies
  3. Financials
  4. Cash from operations

【JP:3417】

Market cap
¥19B
P/E ratio
Oki Healthcare Holdings manages a pharmaceutical group of eight companies that manufacture and sell medicines and related products for the healthcare industry.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 2025-9,184-221.67%
Mar 31, 20247,548+7762.50%
Mar 31, 202396-92.67%
Mar 31, 20221,309-130.63%
Mar 31, 2021-4,273+374.25%
Mar 31, 2020-901-133.00%
Mar 31, 20192,730-51.19%
Mar 31, 20185,593-979.40%
Mar 31, 2017-636-150.32%
Mar 31, 20161,264

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)